What to Expect in Your First Month on Compounded Semaglutide or Tirzepatide

Key takeaways What to expect in your first month on compounded GLP-1 Quick answer: Your first month on compounded GLP-1 is mostly about your body adjusting to the medication, not dramatic weight loss. Some lose 2 to 8 pounds in Month 1, notice appetite changes within one to two weeks, and may have mild nausea […]

By Astra Editorial Team

Published:

Updated:

Key takeaways

  • The first month on compounded semaglutide or compounded tirzepatide is mostly about getting your body used to the medication. Real weight loss usually starts around Weeks 8 to 12, when you’ve titrated up to a higher dose.
  • In Month 1, expect modest appetite changes within the first one to two weeks, some nausea or stomach upset in Weeks 1 through 3 for many people (though some have no side effects at all), and anywhere from 0 to 8 pounds of weight change by Week 4 depending on starting weight and water retention.
  • The first month is also when dosing errors are most likely with compounded GLP-1. The vial-and-syringe setup is unfamiliar, and “units” don’t always mean the same thing between pharmacies.

What to expect in your first month on compounded GLP-1

Quick answer: Your first month on compounded GLP-1 is mostly about your body adjusting to the medication, not dramatic weight loss. Some lose 2 to 8 pounds in Month 1, notice appetite changes within one to two weeks, and may have mild nausea or stomach upset for the first two to three weeks. Real weight loss usually starts around Weeks 8 to 12 at higher doses.

Your first month on compounded GLP-1 is for your body, not for the scale. Compounded GLP-1 medications work by mimicking a hormone your body makes naturally called GLP-1. The medication slows how fast food leaves your stomach, increases the “I’m full” signals your brain gets, and reduces the background hunger most people feel between meals.

Because it’s the first month, it’s also when your provider naturally prescribes the lowest dose. Brand-name semaglutide (Wegovy and Ozempic) always starts at 0.25 mg per week, while brand-name tirzepatide (Zepbound) starts at 2.5 mg. 

Compounded providers, on the other hand, may start you at 0.15 mg, 0.2 mg, or 0.25 mg for compounded semaglutide, or 2.5 mg or lower for compounded tirzepatide, depending on their protocol and your tolerance plan.

Whatever your starting dose, it’s not designed to drive dramatic weight loss in the first month. Instead, it’s for your stomach and digestive system to adjust to a medication that’s slowing them down.

If you finish Week 4 having lost 2 to 5 pounds, that’s a normal response. If you’ve lost more (some people lose 6 to 10 pounds in the first month, mostly water weight), that’s also fine. If you’ve barely lost any weight, that doesn’t mean the compounded GLP-1 isn’t working. The real weight loss starts later, when you’ve titrated up to higher doses (usually Weeks 5 through 16).

A common mistake at Week 3 or 4 is concluding the medication isn’t strong enough and pushing your provider to skip ahead. Don’t. The same dose builds up in your body week over week because of how long the medication stays active (about a 7-day half-life). By Week 4, you have more medication in your system than you did in Week 1, even though you took the same amount each time. The dose does not need to be bigger. It just needs more time to reach steady state, which takes about four to five weeks at any given dose.

There are others who stay at the starting dose for three to six months and lose meaningful weight without ever titrating up. There’s no rule that says you have to escalate every four weeks. The right dose is the lowest one that gives you steady appetite suppression with the fewest side effects.

Thinking about starting? Here’s what happens next.

A licensed clinician reviews your health profile, prescribes the right starting dose, and stays available for questions through your first month and beyond. No guessing, no ghosting.

See if compounded GLP-1 is right for you →

Week 1 on compounded GLP-1: Your first injection

Quick answer: Week 1 is for getting through your first injection and learning what your body’s response looks like. Expect mild nausea or stomach upset 12 to 48 hours after the injection (or none at all), small appetite changes by Days 5 to 7, and 0 to 4 pounds of scale movement, often water weight.

Day 1

You’ll inject into your abdomen, thigh, or upper arm. Pick a day of the week that fits your schedule since consistency matters more than the specific day. Many people pick Sunday evening so a midweek workday isn’t ruined if they feel rough.

Some eat a small protein-rich snack or drink a protein shake right before the injection to buffer the night-of stomach reaction. Not that it’s required, but it can help if you’re worried about nausea hitting overnight.

Most people feel nothing immediately after the injection. The pinch is small. The medication starts working within hours, but you likely won’t feel much that first night.

Days 2-4

Mild nausea may show up, usually peaking 12 to 48 hours after the injection. You might get a headache, feel slightly tired, or notice loose stools. Or you might also feel completely normal and wonder if anything is happening.

Both reactions are typical. Side effects in Week 1 don’t predict how the rest of your treatment will go. People with zero side effects in Week 1 sometimes hit them in Week 3. People who feel rough in Week 1 often feel fine by Week 3.

Days 5-7

Side effects tend to ease toward the end of Week 1. You may notice the first real signs the medication is working: less interest in snacking, feeling full faster than usual, or what people call “food noise” (you’ll see this term used a lot in GLP-1-related articles) dying down. Food noise is the constant background mental chatter about what to eat next, and a lot of people don’t realize they have it until it goes quiet.

What’s typical at the end of Week 1

What’s not typical

If you’re vomiting and can’t keep fluids down, having severe abdominal pain, or feeling lightheaded enough to nearly faint, those are not normal week-1 reactions. Contact your provider.

Week 2 on compounded GLP-1: Settling in

Quick answer: Week 2 is when appetite reduction becomes obvious for most people. You’ll notice you’re full after smaller portions, you’re forgetting to snack, and you’re less interested in food you used to crave. Typical weight change by end of Week 2 is 1 to 4 pounds down.

Day 8

Second injection. The side effects after Dose 2 are usually milder than Dose 1 for most people, since your body has started adjusting. Some people have the opposite experience and feel worse with Dose 2 as the medication builds up. Both are normal.

Days 9-14

This is when appetite reduction becomes obvious for most people. You’ll notice you’re full after smaller portions, you’re forgetting to snack, and you’re less interested in food you used to crave. Some people feel like a switch flipped between Week 1 and Week 2.

Typical weight change by end of Week 2: 1 to 4 pounds down from your starting weight.

Things to watch in Week 2 on compounded GLP-1

Week 3 on compounded GLP-1: Adapting 

Quick answer: By Week 3, appetite reduction is steady and you should focus on getting enough protein. Inadequate protein during weight loss leads to muscle loss along with fat loss. Aim for 0.7 to 1.0 gram of protein per pound of your goal body weight.

Day 15

By now, you have a routine and your body knows what’s coming. Third injection.

Days 16-21

Appetite reduction is steady. Many report not feeling hungry until afternoon, and cravings for high-fat or sugary foods often drop sharply. Some describe feeling “normal” around food for the first time in years.

This is the week to start being intentional about protein. With smaller portions, you can easily under-eat protein, and inadequate protein during weight loss leads to muscle loss along with fat loss. Aim for 0.7 to 1.0 grams of protein per pound of your goal body weight. That’s roughly 100 to 150 grams of protein per day for most adults.

To give you an idea, these are some easy protein sources that fit small appetites: Greek yogurt, eggs, cottage cheese, protein shakes, chicken breast, fish, legumes, tofu. Spread it across the day rather than trying to hit it all at dinner.

Things to watch in Week 3 on compounded GLP-1

Week 4 on compounded GLP-1: What to expect at the end of the starter dose

Quick answer: Week 4 is your first clinical check-in and the point where you and your provider decide whether to titrate up. A good provider doesn’t automatically push you to the next dose. Typical Month 1 weight loss is 2 to 8 pounds, with appetite reduction established and a routine around your injection day.

Day 22

Fourth and (often) final starter-dose injection.

Day 28

First clinical follow-up with your provider. This is when you’d typically review:

A good provider doesn’t automatically push you to the next dose. If side effects are still rough, or if your current dose is giving you steady appetite suppression with no plateau, the right call is often staying at the starter dose for another 4 to 8 weeks before titrating up. 

There’s no clinical rush to increase your dosage. Those who titrate slower tend to stay on the medication longer and lose more weight over the long run.

Day 29

If you and your provider decide to move up, you’d typically go to 0.5 mg per week for semaglutide or 5.0 mg per week for tirzepatide. Some people get a second wave of nausea at the new dose, usually milder than Week 1.

Typical end-of-month results on compounded GLP-1

If you’ve lost more, that’s fine. If you’ve lost less, also fine. The first month is not predictive of total weight loss. Those who lose one pound in Month 1 may lose 30 to 40 pounds by Month 12. The numbers compound at higher doses.

What if the scale didn’t move but your clothes fit differently?

This is common, especially for women, as hormonal water retention can mask actual fat loss for weeks. If your waist measurement, hip measurement, or how your jeans fit has changed, the medication is working even if the scale has not caught up yet. Take measurements at the start of treatment so you have something to compare against beyond weight.

One month from now, you could be one month in.

The health profile takes 5 minutes. A licensed clinician reviews it, and if compounded GLP-1 fits your situation, you’re on your way.

Start your health profile →

Compounded semaglutide vs. compounded tirzepatide: What’s different in Month 1?

Quick answer: Compounded tirzepatide typically produces slightly faster appetite reduction and more weight loss in Month 1 than compounded semaglutide. Tirzepatide activates a second receptor (GIP), which is why clinical trials show larger weight loss numbers. 

Compounded semaglutide Month 1:

Compounded tirzepatide Month 1:

If your provider started you on one and the side effects are unmanageable after three to four weeks at the starter dose, switching to the other is a reasonable conversation to have.

Why dosing errors in compounded GLP-1 are common in Week 1

Quick answer: Compounded GLP-1s come in vials that require you to draw your dose into a syringe, and most Week 1 dosing errors come from confusing units, milligrams, and milliliters. Brand-name pens click to your dose automatically; compounded vials require math.

The most common mistakes:

If your provider didn’t walk you through dose math, syringe selection, and injection technique before your first shot, that’s a quality issue worth flagging. Real care includes setup, not just the prescription. For more on what real compounded GLP-1 care looks like, see our full guide on compounded GLP-1 medications.

Should you split your weekly dose of compounded GLP-1?

Quick answer: Splitting a weekly dose into two smaller injections can reduce side effects for some people, but it’s not standard and requires provider involvement. Don’t decide to split on your own.

The idea is that taking half your weekly dose on Day 1 and the other half on Day 4 produces a steadier level of medication in your system, with smaller peak doses that cause less nausea and stomach upset.

This isn’t standard, and your provider should be involved in the decision. Half-dose injections require more dosing math, more frequent injections, and an understanding of how the medication accumulates in your body. Some compounding pharmacies design their vials for weekly dosing, and splitting can affect how long a vial lasts or how it’s stored.

If you’re having tough side effects at the standard weekly dose, ask your provider whether splitting is an option for your protocol or just ask for a lower dose. Don’t decide to split on your own.

The weird compounded GLP-1 side effects nobody warns you about

Quick answer: Less-known side effects in Month 1 include alcohol hitting harder, carbonation becoming unappealing, food tastes changing, hot flashes, fragmented sleep, and frequent burping. Most settle within a few weeks.

These show up enough in patient anecdotes that they’re worth mentioning, even though they don’t appear in most clinical guides.

How do you manage compounded GLP-1 side effects?

For nausea:

For constipation:

For reflux:

For fatigue:

For headaches:

For injection site reactions:

When to call your provider

Call within 24 hours for:

Call 911 or go to the ER immediately for:

Where to go from here

The first month on compounded GLP-1 is mostly about adjustment. Your body is learning a new baseline. The dramatic weight loss most people are looking for comes later, at higher doses, and those who get there are the ones who set realistic expectations in their first month.

For the bigger picture on whether compounded GLP-1 is right for you, what the safety data actually shows, and how to choose a legitimate provider, see our full guide on compounded GLP-1 medications.

If you’re considering starting compounded GLP-1 treatment, Astra (try-astra.com) prescribes through licensed clinicians at Wasef Health, PC, and fills compounded prescriptions through VialsRx, a US-licensed 503A pharmacy. 

Astra’s microdose protocols start at $89 per month, and compounded semaglutide starts at $96 per month on the 3-month starter plan. Every patient gets clear dosing instructions, the right syringes for their prescribed dose, and ongoing clinical support throughout treatment.

Knowing what to expect is half the battle.

The other half is starting. Astra pairs licensed clinicians with a US-licensed 503A pharmacy so month 1 is guided, not guessed at.

Start your health profile Takes about 5 minutes.

Frequently asked questions

How long until compounded semaglutide starts working?

Most people feel appetite changes within one to two weeks of starting compounded semaglutide, but real weight loss usually starts around Weeks 4 to 8 and accelerates at higher doses. The medication reaches steady-state levels in your blood after four to five weeks, so you won’t feel its full effect at any given dose until then.

What does compounded GLP-1 feel like?

Most people describe it as the mental noise about food going quiet. You’re not hungry at random times, you feel full after smaller meals, and cravings for sugary or fatty foods drop sharply. Some people feel mildly nauseous in the first two weeks, especially within 12 to 48 hours of the injection.

What if I have no side effects at all?

Having no side effects in Month 1 is common and doesn’t mean the medication isn’t working. A meaningful percentage of patients have zero notable side effects in Month 1. If your appetite has reduced and you’re feeling fuller faster, the medication is doing its job.

Will I lose weight in the first month on GLP-1?

Most people lose 2 to 6 pounds on compounded semaglutide and 3 to 8 pounds on compounded tirzepatide in Month 1. Some people lose more (often water weight in the first week). Some lose less. The first month isn’t predictive of total weight loss. The bigger weight loss comes later at higher doses.

What if I’m not losing weight in Week 4 while on GLP-1?

The starter dose is for adjustment, not maximum weight loss, so minimal scale movement in Week 4 is normal. The real test happens after you’ve been on a maintenance dose (0.5 mg or higher for semaglutide, 5 mg or higher for tirzepatide) for at least eight weeks. If you’ve titrated up and still aren’t losing weight by Month 3, talk to your provider.

Should I eat before my GLP-1 injection?

You don’t have to eat before your GLP-1 injection, but a small protein-rich snack can help if you’re worried about overnight nausea. Others inject on an empty stomach and feel fine.

What if I can’t tolerate the dose increase at week 5?

A good provider will keep you at the starter dose for another four to eight weeks rather than pushing you forward when side effects are unmanageable. Slower titration leads to better tolerance, fewer dropouts, and better long-term weight loss.

Can I exercise during the first month on GLP-1?

Yes, and you should. Even 20 minutes of walking per day helps preserve muscle mass while you’re losing weight. Strength training matters more than cardio for maintaining lean mass. Heavy training is fine if you can tolerate it, but you may need to scale back intensity if you’re nauseous or under-eating.

Is the first month on compounded GLP-1 the same as the first month on brand-name?

Mostly yes, but compounded GLP-1s have a few unique challenges in Month 1: the vial-and-syringe setup adds a learning curve, dosing errors are more common, and “units” can mean different amounts between pharmacies. The active ingredient is the same. The experience around it varies more.

References

  1. Enyeama, N. (2026, May 24). First Month on Semaglutide: 2026 Week-by-Week Guide. Tsiyyon Primary Care & Wellness Center.
  2. Sison, G. (2025, March 3). Not losing weight on compounded semaglutide? Here’s why. SingleCare.
  3. McCall, K. L., Mastro Dwyer, K. A., Casey, R. T., et al. (2026). Safety analysis of compounded GLP-1 receptor agonists: a pharmacovigilance study using the FDA adverse event reporting system. Expert Opinion on Drug Safety, 25(3), 581-588.
  4. Wharton, S., Freitas, P., Hjelmesaeth, J., et al. (2025). Once-weekly semaglutide 7.2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial. Lancet Diabetes & Endocrinology, 13(11), 949-963.
  5. US Food and Drug Administration. FDA’s concerns with unapproved GLP-1 drugs used for weight loss.

This article is for educational purposes only and does not constitute medical advice. Consult a licensed physician regarding any medical condition or treatment.